The sneaker company says David Bergman received a Wells Notice indicating he is facing an enforcement action over its accounting practices.
The measures will "harm the governance process and suppress the free and full exercise of shareholder voting rights," a dissenting commissioner says.
The SEC says the biotech firm made improper payments to Turkish and Russian officials to secure favorable treatment for its main drug.
The messaging startup agreed to return the funds to settle charges that its digital asset offering was an unregistered sale of securities.
The SEC says former finance chief Ronald Pipoly failed to properly disclose the company’s process for reporting management’s best estimate of loss reserves.
The SEC says the insurer failed to disclose more than $5.3 million in perks that it provided to former CEO Mark Watson from 2014 through 2018.
The SEC says William Sadleir defrauded a BlackRock fund by using money it had invested in Aviron for personal expenses including a Beverly Hills mansion.
A bipartisan bill could result in Chinese firms being delisted from U.S. exchanges if they do not submit their audit reports to U.S. regulators.
The three auditors agreed to suspensions for violating auditor integrity rules by improperly sharing answers to internal training tests.
The engineering firm is facing investigations into its accounting by the SEC and Department of Justice.
The commission has halted trading in the shares of three companies that have said they are developing a drug candidate for treating COVID-19.
The health-care company allegedly made bogus claims it had created a “direct pipeline from manufacturers and suppliers to buyers” of N95 masks.
